Patent Assignment
Reel/Frame 059432/0709
Security Interest
Recorded: 2022-03-17
Pages: 10
Assignor
LEXICON PHARMACEUTICALS, INC.
Executed: 2022-03-17
Assignee
OXFORD FINANCE LLC, AS COLLATERAL AGENT
115 SOUTH UNION STREET, SUITE 300, ATTN: LEGAL DEPARTMENT, ALEXANDRIA, VIRGINIA, 22314
Covered Properties
(61)
Novel Human Kinases and Polynucleotides Encoding the Same, and Uses Thereof
Patent:
6,858,419 →
Application:
10/010,720 →
Novel Human Hydroxylases and Polynucleotides Encoding the Same
Novel Human Kinases and Polynucleotides Encoding the Same
Patent:
6,797,510 →
Application:
10/196,927 →
Novel Human Kinases and Polynucleotides Encoding the Same
Novel Human Kinases and Polynucleotides Encoding the Same, and Uses Thereof
Novel Human Hydroxylases and Polynucleotides Encoding the Same
Novel Thiazolopyrazoles and Methods of Their Use
Monoclonal Antibodies Against ANGPTL4
Knockout Animals Manifesting Hyperlipidemia
Patent:
7,402,730 →
Application:
11/347,838 →
4-Piperidin-1-Yl-7H-Pyrrolo[2,3-D]Pyrimidine Compounds
Aryl Pyridines and Methods of Their Use
Imidazole-Based Compounds, Compositions Comprising Them and Methods of Their Use
Synthesis of Piperazines, Piperidines and Related Compounds
Inhibitors of Sodium Glucose Co-Transporter 2 and Methods of Their Use
Process for Preparing 5-Alkyl-7H-Pyrrolo[2,3-D] Pyrimindine-2-Ols
4-Amino-1H-Pyrimidin-2-One Based Compounds, Compositions Comprising Them and Methods of Their Use
O-Linked Pyrimidin-4-Amine-Based Compounds, Compositions Comprising Them, and Methods of Their Use to Treat Cancer
Monoclonal Antibodies Against ANGPTL3
Heterocyclic Compounds, Compositions Comprising Them and Methods of Their Use
Piperdine-Based Inhibitors of Sodium Glucose Co-Transporter 2 and Methods of Their Use
Methods of Preparing Imidazole-Based Compounds
Methods of Using and Compositions Comprising Tryptophan Hydroxylase Inhibitors
Methods and Compounds Useful for the Preparation of Sodium Glucose Co-Transporter 2 Inhibitors
Substituted Pyrrolo[2,3-D]Pyrimidines as Lim Kinase 2 Inhibitors
Compositions and Methods for Treating Immunological and Inflammatory Diseases and Disorders
LIMK2 Inhibitors, Compositions Comprising Them, and Methods of Their Use
Solid Forms of (1R,2S,3R)-1-(2-(Isoxazol-3-Yl)-1H-Imidazol-4-Yl)Butane-1,2,3,4-Tetraol and Methods of Their Use
Methods of Preparing Imidazole-Based Bicyclic Compounds
Solid Forms of (2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-Ethoxybenzyl)Phenyl)-6-(Methylthio)Tetrahydro-2H-Pyran-3,4,5-Triol and Methods of Their Use
(E)-1-(4-((1R,2S,3R)-1,2,3,4-Tetrahydroxybutyl)-1H-Imidazol-2-Yl)Ethanone Oxime Dihydrate and Methods of Its Use
Heterocyclic Compounds, Compositions Comprising Them and Methods of Their Use
Methods of Treating Rheumatoid Arthritis
Monoclonal Antibodies Against ANGPTL4
Multicyclic Compounds and Methods of Their Use
Sulfanyl-Tetrahydropyran-Based Compounds and Methods of Their Use
Methods of Preparing Imidazole-Based Compounds
Modulators of G Protein-Coupled Receptor 88
Modulators of G Protein-Coupled Receptor 88
Modulators of G Protein-Coupled Receptor 88
Monoclonal Antibodies Against ANGPTL3
Methods and Compounds Useful for the Preparation of Sodium Glucose Co-Transporter 2 Inhibitors
Solid Forms of 3-(4-(Aminomethyl)-1-(5-Methyl-7H-Pyrrolo[2,3-D]Pyrimidin-4-Yl)Piperidine-4-Carboxamido)Phenyl Dimethylcarbamate
Monoclonal Antibodies Against ANGPTL4
Methods of Treating Ulcerative Colitis
MST1 Kinase Inhibitors and Methods of Their Use
LIMK2 Inhibitors, Compositions Comprising Them, and Methods of Their Use
Methods of Treating Diabetes
Imidazo[1,2-B]Pyridazine-Based Compounds, Compositions Comprising Them, and Methods of Their Use
Pyrazolo[1,5-A]Pyrimidine-Based Compounds, Compositions Comprising Them, and Methods of Their Use
Sodium Glucose Co-Transporter Inhibitors and Methods of Their Use
Inhibitors of Sodium Glucose Cotransporter 1
4H-Thieno[3,2-C]Chromene-Based Inhibitors of Notum Pectinacetylesterase and Methods of Their Use
PYRAZOLO[1,5-a]PYRIMIDINE-BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM, AND METHODS OF THEIR USE
Inhibitors of Adapter Associated Kinase 1, Compositions Comprising Them, and Methods of Their Use
Inhibitors of Sodium Glucose Cotransporter 1
PYRAZOLO[1,5-a]PYRIMIDINE-BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM, AND METHODS OF THEIR USE
Inhibitors of Sodium Glucose Transporter 1 for Constipation
Antibodies That Bind Notum Pectinacetylesterase
Crystalline Solid Forms of N-(1-((2-(Dimethylamino)Ethyl)Amino)-2-Methyl-1-Oxopropan-2-Yl)-4-(4-(2-Methyl-5-((2S,3R,4R,5S,6R)-3,4,5-Trihydroxy-6-(Methylthio)Tetrahydro-2H-Pyran-2-Yl)Benzyl)Phenyl)Butanamide and Methods of Their Synthesis
Compositions Comprising and Methods of Using Inhibitors of Sodium-Glucose Cotransporters 1 and 2
Application:
16/792,803 →
Publication:
US 2021/0038626
Use of Sotagliflozin for the Treatment of Patients with Type 1 Diabetes Mellitus
Application:
16/804,255 →
Publication:
US 2021/0038627
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest
Dec 20, 2017
From: LEXICON PHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 044958/0377 →
Release of Security Interest
Sep 14, 2020
From: BIOPHARMA CREDIT PLC
To: LEXICON PHARMACEUTICALS, INC.
Reel/Frame 053767/0445 →
Change of Name
Feb 24, 2022
From: LEXICON GENETICS INCORPORATED
To: LEXICON PHARMACEUTICALS, INC.
Reel/Frame 059240/0463 →
Corrective Assignment to Correct the Assignee Name Previously Recorded at Reel: 016913 Frame: 0648. Assignor(S) Hereby Confirms the Assignment .
Feb 25, 2022
From: BARBOSA, JOSEPH; FINK, CYNTHIA A; KIMBALL, SPENCER D; KOLB, HARTMUTH
To: LEXICON GENETICS INCORPORATED
Reel/Frame 059248/0212 →
Change of Name
Mar 15, 2022
From: LEXICON GENETICS INCORPORATED
To: LEXICON PHARMACEUTICALS, INC.
Reel/Frame 059368/0159 →